Rheumatology
News, opinions and meeting coverage in rheumatology.
— Greater improvements over apremilast and placebo through 24 weeks
Latest in Rheumatology
Some psoriatic arthritis patients more vulnerable than others in Swedish study
Large claims-based study provides some answers
Roundtable of experts weigh in on "unprecedented" efficacy, and safety issues
Higher quadricep-hamstring ratio associated with 82% lower odds in NIH cohort
Roundtable of experts weigh in on "unprecedented" efficacy, and safety issues
Higher quadricep-hamstring ratio associated with 82% lower odds in NIH cohort
Rheumatology Case Studies
Numerous diagnostic procedures revealed tophaceous gout affecting the middle ear
Joint stiffness is just one symptom of this rare debilitating inflammatory disease
Prompt diagnosis of this rare progressive autoimmune disease may help preserve hearing, eyesight
More in Rheumatology
FDA should consider warning labels based on study results, researchers argue
French researchers think they've identified a truly novel approach
Treatment-resistant juvenile dermatomyositis resolved by targeting elevated interferon-beta
Favorable results with TAK-279 and deucravacitinib in studies at ACR
Liposomal formulation OK for repeat dosing, phase III study indicates
Mechanism different from currently available therapies
Worries about vaccine responsiveness relieved; Big Pharma gets interested
Computer matches live expert in measuring joint space and erosions
More phase II data build case for izokibep
Something to consider when prescribing SGLT-2 inhibitors
Phase II results pave way for bigger and better trial
Placebo-controlled trial gives novel product a tentative boost
Study should help target frequent testing to those most likely to benefit
Secondary trial analysis boosts case for Gazyva
